about
International Biological Engagement Programs Facilitate Newcastle Disease Epidemiological StudiesComplete Genome Sequences of Four Avian Paramyxoviruses of Serotype 10 Isolated from Rockhopper Penguins on the Falkland IslandsTemporal, geographic, and host distribution of avian paramyxovirus 1 (Newcastle disease virus).Presence of Vaccine-Derived Newcastle Disease Viruses in Wild Birds.A robust and cost-effective approach to sequence and analyze complete genomes of small RNA viruses.Identification and Complete Genome Sequence Analysis of a Genotype XIV Newcastle Disease Virus from Nigeria.Complete Genome Sequence of a Genotype XVII Newcastle Disease Virus, Isolated from an Apparently Healthy Domestic Duck in NigeriaNewcastle Disease Viruses Causing Recent Outbreaks Worldwide Show Unexpectedly High Genetic Similarity to Historical Virulent Isolates from the 1940s.Complete Genome Sequence of an Avian Paramyxovirus Representative of Putative New Serotype 13.Complete Genome Sequence of a Virulent Newcastle Disease Virus Strain Isolated from a Clinically Healthy Duck (Anas platyrhynchos domesticus) in Pakistan.Complete Genome Sequence of Genotype VI Newcastle Disease Viruses Isolated from Pigeons in Pakistan.Assessment of contemporary genetic diversity and inter-taxa/inter-region exchange of avian paramyxovirus serotype 1 in wild birds sampled in North America.Genome-wide analysis reveals class and gene specific codon usage adaptation in avian paramyxoviruses 1.Histopathologic Characterization and Shedding Dynamics of Guineafowl (Numida meleagris) Intravenously Infected with a H6N2 Low Pathogenicity Avian Influenza Virus.Repeated Challenge with Virulent Newcastle Disease Virus Does Not Decrease the Efficacy of Vaccines.Repeated isolation of virulent Newcastle disease viruses in poultry and captive non-poultry avian species in Pakistan from 2011 to 2016.Repeated isolation of virulent Newcastle disease viruses of sub-genotype VIId from backyard chickens in Bulgaria and Ukraine between 2002 and 2013.Identification of Avian Paramyxovirus Serotype-1 in Wild Birds in the USA.An Epizootiological Report of the Re-emergence and Spread of a Lineage of Virulent Newcastle Disease Virus into Eastern Europe.Phylogenetic assessment reveals continuous evolution and circulation of pigeon-derived virulent avian avulaviruses 1 in Eastern Europe, Asia, and Africa.Reply to "May Newly Defined Subgenotypes Va and Vb of Newcastle Disease Virus in Poultry Be Considered Two Different Genotypes?".Status of wild birds in Bulgarian zoos with regard to orthomyxovirus and paramyxovirus type 1 infections.Whole-genome sequencing of genotype VI Newcastle disease viruses from formalin-fixed paraffin-embedded tissues from wild pigeons reveals continuous evolution and previously unrecognized genetic diversity in the U.S.Newcastle Disease Virus Infection in Quail.Rapid virulence prediction and identification of Newcastle disease virus genotypes using third-generation sequencingGlobal phylodynamic analysis of avian paramyxovirus-1 provides evidence of inter-host transmission and intercontinental spatial diffusionFirst Complete Genome Sequence of a Subgenotype Vd Newcastle Disease Virus IsolateVirulent Newcastle disease viruses from chicken origin are more pathogenic and transmissible to chickens than viruses normally maintained in wild birdsEnhanced phylogenetic resolution of Newcastle disease outbreaks using complete viral genome sequences from formalin-fixed paraffin-embedded tissue samplesGenomic comparison of Newcastle disease viruses isolated in Nigeria between 2002 and 2015 reveals circulation of highly diverse genotypes and spillover into wild birdsPathogenicity and transmission of virulent Newcastle disease virus from the 2018-2019 California outbreak and related viruses in young and adult chickensUpdated unified phylogenetic classification system and revised nomenclature for Newcastle disease virusPresence of Newcastle disease viruses of sub-genotypes Vc and VIn in backyard chickens and in apparently healthy wild birds from Mexico in 2017Evaluation of Protective Efficacy When Combining Turkey Herpesvirus-Vector Vaccines
P50
Q26779279-07AC54F2-9517-4997-8286-CF1B96B3CE79Q33753630-296B3782-6A93-469B-AEC6-FEA523FA5822Q35899724-E6B464D4-3775-48CC-AC09-023A7B04A6FFQ36132147-D0713FF8-7AB7-4E1F-B7B9-9F75D7A3936CQ36340372-0382147F-2E3E-4599-9277-3BFC89E980ACQ36518693-276B0374-CCBC-45E3-9A6D-45CB4EB6B10DQ36548230-5F44E4ED-41F4-43CA-A320-E9EDBC11082AQ36834757-D044B8EA-91AD-4DF0-971A-E9C29EEC1E90Q37138170-9EF7DE1B-8854-4214-AF66-1E2CC2D78210Q37138173-CA499D85-84AD-4684-8DAF-F4293B1F3696Q37190887-45CAD528-77BD-4C3E-B900-24D1000DF4E8Q37678674-D06AE7DE-F4B2-469E-9AC6-5742FE3A0DA1Q38965481-DEEE9EC8-628F-49C5-A9B4-2E5DBAF3F9C1Q39679294-4B917EBE-B54F-471A-9F33-F7D7A9CB003BQ40139721-A803EF40-1D33-4E10-9968-1D30EBF8C3E2Q40162914-861C0B07-86D4-4D77-99ED-19F14AB0EDD6Q40401684-D024CD8B-144E-4C49-8897-9AA676D3C8B3Q40727438-1E0AB848-A679-4960-B654-3BD29F35038DQ41047724-1C64CEE2-EC82-45F3-B796-574863080DF4Q41670571-792197D4-5198-49D7-81CB-F675F88CEB13Q41870218-9B10F7A6-1087-40C8-9DBB-64CD35FDAE3FQ43617541-0BDBC047-B6C1-456C-898D-3251B9F990CDQ47554265-D7150351-912A-4E15-BC01-533266AF7333Q53692476-7C5AD7AE-786E-4982-ABF7-CF9B35C05170Q59335985-F27AD23F-940F-4027-B3BD-F3E5D605A7CBQ64284780-6F444258-215F-43A5-A97C-90711C1DCE69Q91592806-9BA230CC-19DB-4EC2-9553-DE45C1F22EE0Q91697521-DE661876-DC67-4BD8-96D7-DA0AB0561BB4Q92027527-6B623908-A44F-48E2-B10D-4367AC538608Q92260468-23642CB3-AB51-429C-95CE-EEBD4F5B3D59Q92719071-F428CF0F-75EE-443F-BEF3-E53564F125BDQ92753384-31E99CA6-5F08-47A7-89F3-9B388B490C4CQ93047715-D33E16BE-32FD-4114-BC5E-02F1F047EDD0Q93102217-5743449B-36D8-4583-ABB7-87DE02285628
P50
description
investigador
@es
researcher
@en
name
Kiril M Dimitrov
@en
type
label
Kiril M Dimitrov
@en
prefLabel
Kiril M Dimitrov
@en
P31
P496
0000-0002-5525-4492